Response to chemotherapy in relapsed low-grade serous ovarian carcinoma: Royal Marsden series of 46 patients

被引:1
|
作者
McLachlan, J. M. [1 ]
Tunariu, N. [1 ]
Lima, J. P. [1 ]
George, A. [1 ]
Gore, M. [1 ]
Kaye, S. [1 ]
Banerjee, S. [1 ]
机构
[1] Royal Marsden Hosp NHS Fdn Trust, Gynaecol Unit, London, England
关键词
D O I
10.1093/annonc/mdw374.28
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
881P
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Complete Response With Trametinib in Advanced Low-Grade Serous Ovarian Carcinoma: A Case Report
    Meireles, Pedro Antunes
    Mira, Beatriz
    Vaz, Fatima
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [32] Chemotherapy response in low-grade serous ovarian carcinoma at a comprehensive cancer center: readdressing the roles of platinum and cytotoxic therapies
    Manning-Geist, Beryl L.
    Kahn, Ryan M.
    Nemirovsky, David
    Girshman, Jeffrey
    Laibangyang, Anya
    Gordhandas, Sushmita
    Iasonos, Alexia
    Chui, M. Herman
    Roche, Kara Long
    Zivanovic, Oliver
    Chi, Dennis S.
    Aghajanian, Carol
    Grisham, Rachel N.
    CANCER, 2023, 129 (13) : 2004 - 2012
  • [33] Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
    Dey, Puja
    Nakayama, Kentaro
    Razia, Sultana
    Ishikawa, Masako
    Ishibashi, Tomoka
    Yamashita, Hitomi
    Kanno, Kosuke
    Sato, Seiya
    Kiyono, Tohru
    Kyo, Satoru
    CANCERS, 2022, 14 (06)
  • [34] Stage I low-grade serous ovarian cancer: Is there a benefit to chemotherapy?
    Vue, Nujsaubnusi
    Horne, Zachary
    Crafton, Sarah
    Krivak, Thomas
    Miller, Eirwen
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S286 - S286
  • [35] Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor
    Kanno, Kosuke
    Nakayama, Kentaro
    Razia, Sultana
    Islam, Sohel Hasibul
    Farzana, Zahan Umme
    Sonia, Shahataj Begum
    Sasamori, Hiroki
    Yamashita, Hitomi
    Ishibashi, Tomoka
    Ishikawa, Masako
    Imamura, Kayo
    Ishikawa, Noriyoshi
    Kyo, Satoru
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (09) : 9376 - 9385
  • [36] BORDERLINE AND LOW-GRADE SEROUS OVARIAN CARCINOMA: ANALYSIS OF THE CLINICAL BEHAVIOR IN 151 PATIENTS
    Rotsaert, A.
    Moerman, P.
    Leunen, K.
    Amant, F.
    Neven, P.
    Vergote, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [37] Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma
    Santillan, A.
    Kim, Y. W.
    Zahurak, M. L.
    Gardner, G. J.
    Giuntoli, R. L., II
    Shih, I. M.
    Bristow, R. E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (03) : 601 - 606
  • [38] Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma
    Fernandez, Marta Llaurado
    Dawson, Amy
    Kim, Hannah
    Lam, Nicole
    Russell, Holly
    Bruce, Maegan
    Bittner, Madison
    Hoenisch, Joshua
    Scott, Stephanie A.
    Talhouk, Aline
    Chiu, Derek
    Provencher, Diane
    Nourmoussavi, Melica
    DiMattia, Gabriel
    Lee, Cheng-Han
    Gilks, C. Blake
    Kobel, Martin
    Carey, Mark S.
    GYNECOLOGIC ONCOLOGY, 2020, 157 (01) : 12 - 20
  • [39] Skin Metastasis of Low-Grade Ovarian Serous Carcinoma: A Case Report
    Ching, Lauren M.
    Tran, Benjamin A.
    Russomanno, Kristen L.
    Cardis, Michael A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)
  • [40] Molecular Surrogate Subtypes of Ovarian and Peritoneal Low-grade Serous Carcinoma
    Da-Anoy, Annalyn
    Kang, Eun Young
    Lee, Cheng Han
    Cheasley, Dane
    Fernandez, Marta Llaurado
    Carey, Mark S.
    Cameron, Anna
    Kobel, Martin
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2024, 43 (06) : 617 - 625